Voyager Therapeutics (VYGR) Tops Q1 EPS by 6c

Voyager Therapeutics (NASDAQ: VYGR) reported Q1 EPS of ($0.47), $0.06 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $8.17 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
• Ophir Metals names Eric Tsung as new CFO
• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short